allantoin has been researched along with Lupus Erythematosus, Systemic in 1 studies
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with systemic lupus erythematosus (SLE) experience excess morbidity and mortality due to coronary artery disease (CAD) that cannot be fully explained by the classical CAD risk factors." | 2.71 | Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study. ( Benzie, IF; Griffith, JF; Lee, KK; Lee, VW; Leung, VY; Li, EK; Lim, PL; Tam, LS; Thomas, GN; Tomlinson, B; Whitney, B, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tam, LS | 1 |
| Li, EK | 1 |
| Leung, VY | 1 |
| Griffith, JF | 1 |
| Benzie, IF | 1 |
| Lim, PL | 1 |
| Whitney, B | 1 |
| Lee, VW | 1 |
| Lee, KK | 1 |
| Thomas, GN | 1 |
| Tomlinson, B | 1 |
1 trial available for allantoin and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study.
Topics: Allantoin; Antioxidants; Ascorbic Acid; Biomarkers; Dietary Supplements; Double-Blind Method; Drug T | 2005 |